Fondaparinux treatment in heparin induced thrombocytopenia: A case report Heparine baǧlı trombositopeninin tedavisinde fondaparinuks: Birolgu sunumu


Özsu S., KORKMAZ A., BÜLBÜL Y., ÖZTUNA F., Özlü T.

Tuberkuloz ve Toraks, cilt.59, sa.2, ss.178-183, 2011 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 59 Sayı: 2
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5578/tt.1692
  • Dergi Adı: Tuberkuloz ve Toraks
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.178-183
  • Anahtar Kelimeler: Dalteparin, fondaparinux, heparin induced thrombocytopenia, pulmonary thromboembolism
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Heparin induced thrombocytopenia is a serious complication of heparin therapy that has a high levels of morbidity and mortality due to thrombotic complications. Heparin induced thrombocytopenia usually develops between days 5 and 14 (inclusive) following initiation of heparin. When heparin induced thrombocytopenia is suspected, heparin should be discontinued and treatment with a direct thrombin inhibitor should be initiated. Heparin induced thrombocytopenia occurs more frequently with unfractionated heparin than with low molecular weight heparin. In this manuscript, we presented a case diagnosis with heparin induced thrombocytopenia who was given low molecular weight heparin for prophylaxis. We tried to make an overview of new treatment choices along with current literature.